Cancer treatment planning involves many difficult decisions. It uses data from sources like imaging studies, pathology reports, genetic tests, and electronic health records (EHRs). Doctors need to look at a lot of this data to create care plans tailored to each patient. Research shows that less than 1% of the 20 million cancer patients diagnosed worldwide each year get personalized treatment plans from tumor boards, where experts review different types of patient data.
Many traditional AI systems act like “black boxes.” They give advice but do not explain how they reached their decisions. This can make doctors hesitant. They want to check and confirm AI suggestions before using them with patients. Explainable AI (XAI) helps by making the AI’s reasoning clear and easy to understand. This builds trust in the AI and helps confirm that the AI’s advice follows medical rules and standards.
A study by Ibomoiye Domor Mienye and others shows the challenge of balancing how accurate and how understandable healthcare AI systems are. Very accurate AI might be complicated and hard to understand. Simpler AI is easier to follow but might not always be as precise. Finding the right balance is important in cancer care because decisions can have big effects.
Trust is key to accepting any new technology in healthcare, especially when lives depend on it. Explainable AI helps build trust by letting doctors:
Ethics are important too. Medical groups need to make sure AI doesn’t cause unfair treatment or break patient privacy. Explainability helps doctors and managers see if the AI follows rules and ethical standards. This is very important because healthcare in the U.S. has many strict laws.
Research also says explainability helps with accountability. When doctors can review AI reasons, they keep control over decisions. This keeps humans in charge and makes sure AI aids but does not replace doctors in treatment planning. This also lowers legal risks for hospitals using AI.
One new tool is the healthcare agent orchestrator. It brings together many AI agents that focus on different tasks. This improves cancer care workflows. This platform, found in Microsoft’s Azure AI Foundry Agent Catalog, connects AI that looks at different data like images, slides, genetic data, and notes from electronic records.
Supported by places like Stanford Health Care, Johns Hopkins, and the University of Wisconsin, this system shortens doctor review time from hours to minutes. For example, Stanford Medicine sees about 4,000 tumor board patients every year. They use summaries made by AI to quickly explain complex clinical data during meetings.
The AI agents in the orchestrator can:
It also works with tools like Microsoft Teams, Word, and PowerPoint. This lets doctors work with AI help in programs they already use. This setup keeps humans involved, which is important for safety and control.
Using AI, especially Explainable AI, in cancer care brings opportunities and challenges for healthcare administrators and IT managers. These workers must make sure AI meets clinical, ethical, and legal needs while helping the hospital run smoothly.
Key points to consider include:
Time matters a lot in cancer treatment planning. Doctors often spend 1.5 to 2.5 hours per patient reviewing data like images, pathology slides, genetics, and clinical notes. This long process can slow decisions, add extra work, and tire clinicians.
AI workflow automation helps by using special AI agents organized by platforms like the healthcare agent orchestrator. The automation can:
Stanford Health Care Chief Information Officer Dr. Mike Pfeffer says this automation stops work from breaking up and makes tumor board meetings faster. Dr. Joshua Warner from UW Health notes that hours of review can shrink to minutes. This change can help more personalized cancer care spread across the U.S.
For administrators and IT staff, using such AI automation can improve how smoothly and well hospitals run without overloading doctors.
Although AI has many benefits, healthcare organizations in the U.S. must think about practical and ethical points before using it fully:
Leading cancer centers like Stanford Health Care, Johns Hopkins, Providence Genomics, and the University of Wisconsin are working with companies like Microsoft and Paige.ai to improve AI tools that focus on being clear and trustworthy. As AI grows, medical practice owners and managers in the U.S. need to keep learning about what these tools can and cannot do.
Good cancer care depends on smoothly combining detailed data, AI insights, and trusted doctor workflows. Explainable AI helps by making things clear, ethical, and reliable so doctors can confidently make choices that affect patient lives. Hospitals and clinics that use these AI systems may improve how accurate, fast, and good cancer treatment planning is, while meeting legal rules.
For medical practice administrators and IT managers in the U.S., explainable AI platforms that support cancer treatment planning offer both advantages and duties. Focusing on clear AI explanations helps build doctor trust and keep up with healthcare laws. AI workflow automation cuts down on slow manual work, letting care teams spend time better.
By understanding explainable AI basics, implementation challenges, and new progress from top groups, healthcare organizations in the U.S. can prepare to use AI in ways that improve patient care without losing accountability or trust. The future of cancer treatment planning will likely rely on a balance where human knowledge and AI work together clearly and responsibly.
The healthcare agent orchestrator is a platform available in the Azure AI Foundry Agent Catalog designed to coordinate multiple specialized AI agents. It streamlines complex multidisciplinary healthcare workflows, such as tumor boards, by integrating multimodal clinical data, augmenting clinician tasks, and embedding AI-driven insights into existing healthcare tools like Microsoft Teams and Word.
It leverages advanced AI models that combine general reasoning with healthcare-specific modality models to analyze and reason over various data types including imaging (DICOM), pathology whole-slide images, genomics, and clinical notes from EHRs, enabling actionable insights grounded on comprehensive multimodal data.
Agents include the patient history agent organizing data chronologically, the radiology agent for second reads on images, the pathology agent linked to external platforms like Paige.ai’s Alba, the cancer staging agent referencing AJCC guidelines, clinical guidelines agent using NCCN protocols, clinical trials agent matching patient profiles, medical research agent mining medical literature, and the report creation agent automating detailed summaries.
By automating time-consuming data reviews, synthesizing medical literature, surfacing relevant clinical trials, and generating comprehensive reports efficiently, it reduces preparation time from hours to minutes, facilitates real-time AI-human collaboration, and integrates seamlessly into tools like Teams, increasing access to personalized cancer treatment planning.
The platform connects enterprise healthcare data via Microsoft Fabric and FHIR data services and integrates with Microsoft 365 productivity tools such as Teams, Word, PowerPoint, and Copilot. It supports external third-party agents via open APIs, tool wrappers, or Model Context Protocol endpoints for flexible deployment.
Explainability grounds AI outputs to source EHR data, which is critical for clinician validation, trust, and adoption especially in high-stakes healthcare environments. This transparency allows clinicians to verify AI recommendations and ensures accountability in clinical decision-making.
Leading institutions like Stanford Medicine, Johns Hopkins, Providence Genomics, Mass General Brigham, and University of Wisconsin are actively researching and refining the orchestrator. They use it to streamline workflows, improve precision medicine, integrate real-world evidence, and evaluate impacts on multidisciplinary care delivery.
Multimodal AI models integrate diverse data types — images, genomics, text — to produce holistic insights. This comprehensive analysis supports complex clinical reasoning, enabling agents to handle sophisticated tasks such as cancer staging, trial matching, and generating clinical reports that incorporate multiple modalities.
Developers can create, fine-tune, and test agents using their own models, data sources, and instructions within a guided playground. The platform offers open-source customization, supports integration via Microsoft Copilot Studio, and allows extension using Model Context Protocol servers, fostering innovation and rapid deployment in clinical settings.
The orchestrator is intended for research and development only; it is not yet approved for clinical deployment or direct medical diagnosis and treatment. Users are responsible for verifying outputs, complying with healthcare regulations, and obtaining appropriate clearances before clinical use to ensure patient safety and legal compliance.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
